Table 2 Details of age categories
From: Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis
Study name | Study type | Period | Disease | Location | study size | Follow up | Age (group 1) years | Age(group 2)years | RR | 95% |
|---|---|---|---|---|---|---|---|---|---|---|
Campbell, 2009 [10] | cross-sectional | 1998-2005 | CKD | BT, UK | 3439 | -- | > = 50 (Indinavir) | < 50 | 4.92 | 1.31, 18.4 |
Campbell, 2009 [10] | cross-sectional | 1998-2005 | CKD | UK | 3439 | -- | > = 50 (Tenofovir) | < 50 | 5.42 | 1.71, 16.8 |
Crane, 2007 [4] | Cohort | 2001-2006 | Kidney dysfunction | WA, USA | 445 | -- | 30-40 | < 30 | 0.90 | 0.2, 3.2 |
Crane, 2007 [4] | Cohort | 2001-2006 | Kidney dysfunction | USA | 445 | -- | 40-50 | < 30 | 2.10 | 0.6, 7.6 |
Crane, 2007 [4] | Cohort | 2001-2006 | Kidney dysfunction | USA | 445 | -- | > 50 | < 40 | 4.40 | 1.1, 17.2 |
Franey, 2009 [13] | Cohort | 2004-2007 | RI | South Africa | 2189 | -- | > 40 | < 30 | 4.65 | 3.54, 6.10 |
Ganesan, 2010 [14] | Cohort | 1986-2008 | CKD | USA | 4044 | 6.5 | > = 35 | < 35 | 2.6 | 1.7, 4.0 |
Lucas, 2007 [20] | Cohort | 1988-2004 | CKD | MD, USA | 4509 | 4.6 | 30-49.9 | < 30 | 1.50 | 0.7, 3.3 |
Lucas, 2007 [20] | Cohort | 1988-2004 | CKD | USA | 4509 | 4.6 | > = 50 | < 50 | 2.00 | 0.8, 4.7 |